Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.
Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.
复制标题
DOI:
10.1073/pnas.2200083119
复制
发表时间:
2022-03-08
影响因子:
11.1
通讯作者:
Gachon F
中科院分区:
文献类型:
--
作者:
Jouffe C;Weger BD;Martin E;Atger F;Weger M;Gobet C;Ramnath D;Charpagne A;Morin-Rivron D;Powell EE;Sweet MJ;Masoodi M;Uhlenhaut NH;Gachon F
While increasing evidence associates the disruption of circadian rhythms with pathologic conditions, including obesity, type 2 diabetes, and nonalcoholic fatty liver diseases (NAFLD), the involved mechanisms are still poorly described. Here, we show that, in both humans and mice, the pathogenesis of NAFLD is associated with the disruption of the circadian clock combined with perturbations of the growth hormone and sex hormone pathways. However, while this condition protects mice from the development of fibrosis and insulin resistance, it correlates with increased fibrosis in humans. This suggests that the perturbation of the circadian clock and its associated disruption of the growth hormone and sex hormone pathways are critical for the pathogenesis of metabolic and liver diseases. Obesity and liver diseases are associated with the disruption of the circadian clock that orchestrates mammalian physiology to optimize nutrient metabolism and storage. Here, we show that the activity of the circadian clock regulator Brain and Muscle Aryl hydrocarbon receptor nuclear translocator-like 1 (BMAL1) is perturbed during liver fibrosis in humans. To understand the impact of BMAL1 perturbation in obesity and liver diseases, we assessed the impact of a high fat diet or leptin deficiency on Bmal1 knockout mice. While Bmal1 knockout mice were prone to obesity, they were protected against insulin resistance, hepatic steatosis, inflammation, and fibrosis. In addition, to direct the transcriptional regulation of metabolic programs by BMAL1, we show that the disruption of the growth hormone and sex hormone pathways plays a critical role in this protection. Similar endocrine perturbations correlate with the development of liver fibrosis in humans but were absent in hepatocyte-specific Bmal1 knockout mice. This suggests that systemic endocrine perturbation associated with the global disruption of BMAL1 activity is critical for the pathogenesis of metabolic and liver diseases.
登录
查看更多内容
影响因子:
4
作者:
Chakrabarti A;Membrez M;Morin-Rivron D;Siddharth J;Chou CJ;Henry H;Bruce S;Metairon S;Raymond F;Betrisey B;Loyer C;Parkinson SJ;Masoodi M
通讯作者:
Masoodi M
影响因子:
8.1
作者:
Dyar KA;Ciciliot S;Wright LE;Biensø RS;Tagliazucchi GM;Patel VR;Forcato M;Paz MI;Gudiksen A;Solagna F;Albiero M;Moretti I;Eckel-Mahan KL;Baldi P;Sassone-Corsi P;Rizzuto R;Bicciato S;Pilegaard H;Blaauw B;Schiaffino S
通讯作者:
Schiaffino S
DOI:
10.1038/ijo.2015.102
发表时间:
2015-10
期刊:
International journal of obesity (2005)
影响因子:
--
作者:
Dakin RS;Walker BR;Seckl JR;Hadoke PW;Drake AJ
通讯作者:
Drake AJ
影响因子:
4.8
作者:
Coschigano, KT;Holland, AN;Kopchick, JJ
通讯作者:
Kopchick, JJ
影响因子:
2.7
作者:
Benjamini, Yoav;Krieger, Abba M.;Yekutieli, Daniel
通讯作者:
Yekutieli, Daniel